<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35266533</PMID><DateCompleted><Year>2022</Year><Month>10</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2047-4881</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>13</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>18</Day></PubDate></JournalIssue><Title>European journal of preventive cardiology</Title><ISOAbbreviation>Eur J Prev Cardiol</ISOAbbreviation></Journal><ArticleTitle>Cardiopulmonary assessment prior to returning to high-hazard occupations post-symptomatic COVID-19 infection: a position statement of the Aviation and Occupational Cardiology Task Force of the European Association of Preventive Cardiology.</ArticleTitle><Pagination><StartPage>1724</StartPage><EndPage>1730</EndPage><MedlinePgn>1724-1730</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">zwac041</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/eurjpc/zwac041</ELocationID><Abstract><AbstractText>This article provides an overview of the recommendations of the Aviation and Occupational Cardiology Task Force of the European Association of Preventive Cardiology on returning individuals to work in high-hazard occupations (such as flying, diving, and workplaces that are remote from healthcare facilities) following symptomatic Coronavirus Disease 2019 (COVID-19) infection. This process requires exclusion of significant underlying cardiopulmonary disease and this consensus statement (from experts across the field) outlines the appropriate screening and investigative processes that should be undertaken. The recommended response is based on simple screening in primary healthcare to determine those at risk, followed by first line investigations, including an exercise capacity assessment, to identify the small proportion of individuals who may have circulatory, pulmonary, or mixed disease. These individuals can then receive more advanced, targeted investigations. This statement provides a pragmatic, evidence-based approach for those (in all occupations) to assess employee health and capacity prior to a return to work following severe disease, or while continuing to experience significant post-COVID-19 symptoms (so-called 'long-COVID' or post-COVID-19 syndrome).</AbstractText><CopyrightInformation>&#xa9; Crown copyright 2022.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rienks</LastName><ForeName>Rienk</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Central Military Hospital, University Hospital, Lundlaan 1, 3584 EZ Utrecht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holdsworth</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Defence COVID-19 Recovery Service, Defence Medical Rehabilitation Centre, Stanford Hall, Stanford Hall Estate, Stanford On Soar, Loughborough, Leicestershire, LE12 5QW, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Oxford University Hospitals NHS Foundation Trust, Headley Way, Oxford OX3 9DU, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davos</LastName><ForeName>Constantinos H</ForeName><Initials>CH</Initials><Identifier Source="ORCID">0000-0002-0321-7569</Identifier><AffiliationInfo><Affiliation>Biomedical Research Foundation, Academy of Athens, 4 Soranou Ephessiou St., 115 27 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halle</LastName><ForeName>Martin</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3065-530X</Identifier><AffiliationInfo><Affiliation>Department of Prevention, Rehabilitation and Sports Medicine, Medical Faculty, University Hospital, Technical University Munich, Georg-Brauchle-Ring 56, Munchen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>Alexander</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Defence COVID-19 Recovery Service, Defence Medical Rehabilitation Centre, Stanford Hall, Stanford Hall Estate, Stanford On Soar, Loughborough, Leicestershire, LE12 5QW, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Academic Department of Military Rehabilitation, Defence Medical Rehabilitation Centre, Stanford Hall, Stanford on Soar, Loughborough LE12 5QN, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parati</LastName><ForeName>Gianfranco</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-9402-7439</Identifier><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Milano-Bicocca, Piazza dell'Ateneo Nuovo, 1, Milan, Province of Milan 20126, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Istituto Auxologico Italiano, IRCCS, San Luca Hospital, Mos&#xe8; Bianchi Street, 90 - 20149 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guettler</LastName><ForeName>Norbert</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Air Force Centre of Aerospace Medicine, Fuerstenfeldbruck, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicol</LastName><ForeName>Edward D</ForeName><Initials>ED</Initials><AffiliationInfo><Affiliation>Defence COVID-19 Recovery Service, Defence Medical Rehabilitation Centre, Stanford Hall, Stanford Hall Estate, Stanford On Soar, Loughborough, Leicestershire, LE12 5QW, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Royal Brompton Hospital, Sydney Street, London, SW3 6NP, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biomedical Engineering and Imaging Sciences, Kings College, London, Strand London, WC2R 2LS, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Prev Cardiol</MedlineTA><NlmUniqueID>101564430</NlmUniqueID><ISSNLinking>2047-4873</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur J Prev Cardiol. 2022 Jul 20;29(9):e290. doi: 10.1093/eurjpc/zwac066</RefSource><PMID Version="1">35403202</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Eur J Prev Cardiol. 2022 Oct 18;29(13):1721-1723. doi: 10.1093/eurjpc/zwac072</RefSource><PMID Version="1">35945898</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009790" MajorTopicYN="N">Occupations</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002309" MajorTopicYN="Y">Cardiology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001359" MajorTopicYN="Y">Aviation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cardiopulmonary disease</Keyword><Keyword MajorTopicYN="N">High-hazard occupations</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post-COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">&#x2003;SARS-CoV-2</Keyword></KeywordList><CoiStatement>Conflict of interest: none declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>10</Day><Hour>8</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35266533</ArticleId><ArticleId IdType="pmc">PMC8992320</ArticleId><ArticleId IdType="doi">10.1093/eurjpc/zwac041</ArticleId><ArticleId IdType="pii">6546289</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Elliott J, Whitaker M, Bodinier B, Riley S, Ward H, Cooke G, Darzi A, Chadeau-Hyam M, Elliott P.. Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people. PLoS Med 2021;18:e1003777. 10.1371/journal.pmed.1003777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003777</ArticleId><ArticleId IdType="pmc">PMC8478234</ArticleId><ArticleId IdType="pubmed">34582457</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM.. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72&#x202f;314 cases from the Chinese center for disease control and prevention. JAMA 2020;323:1239&#x2013;1242.</Citation><ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Popkin BM, Du S, Green WD, Beck MA, Algaith T, Herbst CH, Alsukait RF, Alluhidan M, Alazemi N, Shekar M.. Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships. Obes Rev 2020;21:e13128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461480</ArticleId><ArticleId IdType="pubmed">32845580</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC.. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol 2020;17:543&#x2013;558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7370876</ArticleId><ArticleId IdType="pubmed">32690910</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim S, Bae JH, Kwon HS, Nauck MA.. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol 2021;17:11&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7664589</ArticleId><ArticleId IdType="pubmed">33188364</ArticleId></ArticleIdList></Reference><Reference><Citation>Muhamad SA, Ugusman A, Kumar J, Skiba D, Hamid AA, Aminuddin A.. COVID-19 and hypertension: the what, the why, and the how. Front Physiol 2021;12:665064.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8126692</ArticleId><ArticleId IdType="pubmed">34012410</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpal S, Tong MS, Borchers J, Zareba KM, Obarski TP, Simonetti OP, Daniels CJ.. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol 2021;6:116&#x2013;118. Erratum in: JAMA Cardiol 2021 Jan 1;6(1):123.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489396</ArticleId><ArticleId IdType="pubmed">32915194</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, Shchendrygina A, Escher F, Vasa-Nicotera M, Zeiher AM, Vehreschild M, Nagel E.. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;5:1265&#x2013;1273. Erratum in: JAMA Cardiol 2020 Nov 1;5(11):1308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendrickson BS, Stephens RE, Chang JV, Amburn JM, Pierotti LL, Johnson JL, Hyden JC, Johnson JN, Philip RR.. Cardiovascular evaluation after COVID-19 in 137 collegiate athletes: results of an algorithm-guided screening. Circulation 2021;143:1926&#x2013;1928.</Citation><ArticleIdList><ArticleId IdType="pubmed">33970675</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry C, Mangion K.. Cardiovascular complications are very uncommon in healthcare workers with mild or asymptomatic COVID-19 infection. JACC Cardiovasc Imaging 2021;14:2167&#x2013;2169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8105427</ArticleId><ArticleId IdType="pubmed">34119431</ArticleId></ArticleIdList></Reference><Reference><Citation>Halle M, Bloch W, Niess AM, Predel H-G, Reinsberger C, Scharhag J, Steinacker J, Wolfarth B, Scherr J, Niebauer J.. Exercise and sports after COVID-19&#x2014;guidance from a clinical perspective. Transl Sports Med 2021;4:310&#x2013;318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250714</ArticleId><ArticleId IdType="pubmed">34230908</ArticleId></ArticleIdList></Reference><Reference><Citation>
Office for National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK. 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/1april2021 (24 May 2021).</Citation></Reference><Reference><Citation>Demeco A, Marotta N, Barletta M, Pino I, Marinaro C, Petraroli A, Moggio L, Ammendolia A.. Rehabilitation of patients post-COVID-19 infection: a literature review. J Int Med Res 2020;48:300060520948382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7450453</ArticleId><ArticleId IdType="pubmed">32840156</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Institute for Healthcare Excellence. Guideline COVID-19 rapid guideline: managing the long-term effects of COVID-19NICE guideline [NG188]. 2020. https://www.nice.org.uk/guidance/ng188(24 May 2021).</Citation></Reference><Reference><Citation>Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD, Reeves WC, Lloyd A; Dubbo Infection Outcomes Study Group. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ 2006;333:575.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan K-Y, Kok AAL, Eikelenboom M, Horsfall M, J&#xf6;rg F, Luteijn RA, Rhebergen D, Oppen P. V, Giltay EJ, Penninx BWJH.. The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts. Lancet Psychiatry 2021;8:121&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7831806</ArticleId><ArticleId IdType="pubmed">33306975</ArticleId></ArticleIdList></Reference><Reference><Citation>Chamley RR, Holdsworth DA, D'arcy JL, Nicol ED.. An Introduction to Occupational Cardiology. Eur Heart J 2019;40:2389&#x2013;2392.</Citation><ArticleIdList><ArticleId IdType="pubmed">31539911</ArticleId></ArticleIdList></Reference><Reference><Citation>Holdsworth DA, Eveson LJ, Manen O, Nicol ED.. Assessment of clinical and occupational cardiovascular risk. Eur Heart J 2019;40:2392&#x2013;2395.</Citation><ArticleIdList><ArticleId IdType="pubmed">31539912</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Sullivan O. Long-term sequelae following previous coronavirus epidemics. Clin Med (Lond) 2021;21:e68&#x2013;e70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7850177</ArticleId><ArticleId IdType="pubmed">33144403</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Sullivan O, Barker-Davies R, Chamley R, Sellon E, Jenkins D, Burley R, Holden L, Nicol AM, Phillip R, Bennett AN, Nicol E, Holdsworth DA.. Defence medical rehabilitation centre (DMRC) COVID-19 recovery service. BMJ Mil Health 2021;e001681.</Citation><ArticleIdList><ArticleId IdType="pubmed">33547188</ArticleId></ArticleIdList></Reference><Reference><Citation>
Panait CI, Peco-Arregui C; on behalf of the Medical Expert Group. European Aviation Safety Agency (EASA). Guidelines for Aero-Medical Centres and Aeromedical Examiners regarding the examination and assessment of applicants: guidelines in relation to the COVID-19 pandemic. 2021. https://www.easa.europa.eu/sites/default/files/dfu/guidelines_for_aemcs_and_ames_regarding_the_examination_and_assessment_of_applicants.pdf (15 June 2021).</Citation></Reference><Reference><Citation>
The Diving Medical Advisory Committee. Return to diving after Covid-19. 2020. http://www.dmac-diving.org/guidance/DMAC33.pdf (15 June 2021).</Citation></Reference><Reference><Citation>Goodman BP, Khoury JA, Blair JE, Grill MF.. COVID-19 dysautonomia. Front Neurol 2021;12:624968.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8076737</ArticleId><ArticleId IdType="pubmed">33927679</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker-Davies RM, O'Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S, Ellis H, Goodall D, Gough M, Lewis S, Norman J, Papadopoulou T, Roscoe D, Sherwood D, Turner P, Walker T, Mistlin A, Phillip R, Nicol AM, Bennett AN, Bahadur S.. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med 2020;54:949&#x2013;959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7418628</ArticleId><ArticleId IdType="pubmed">32475821</ArticleId></ArticleIdList></Reference><Reference><Citation>Chilazi M, Duffy EY, Thakkar A, Michos ED.. COVID and cardiovascular disease: what we know in 2021. Curr Atheroscler Rep 2021;23:37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8117457</ArticleId><ArticleId IdType="pubmed">33983522</ArticleId></ArticleIdList></Reference><Reference><Citation>Holdsworth DA, Chamley RR, Rider OJ, Nicol ED.. The importance of exercise testing in occupational cardiovascular assessment for high-hazard professions. Eur Heart J 2019;40:3078&#x2013;3080.</Citation><ArticleIdList><ArticleId IdType="pubmed">31573033</ArticleId></ArticleIdList></Reference><Reference><Citation>Baratto C, Caravita S, Faini A, Perego GB, Senni M, Badano LP, Parati G.. Impact of COVID-19 on exercise pathophysiology: a combined cardiopulmonary and echocardiographic exercise study. J ApplPhysiol (1985) 2021;130:1470&#x2013;1478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8143785</ArticleId><ArticleId IdType="pubmed">33764166</ArticleId></ArticleIdList></Reference><Reference><Citation>Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE.. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002;346:793&#x2013;801.</Citation><ArticleIdList><ArticleId IdType="pubmed">11893790</ArticleId></ArticleIdList></Reference><Reference><Citation>Kannel WB. Lipids, diabetes, and coronary heart disease: insights from the Framingham Study. Am Heart J 1985;110:1100&#x2013;1107.</Citation><ArticleIdList><ArticleId IdType="pubmed">4061265</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon AS, Connett J, Jacobs DR, Rauramaa R.. Leisure-time physical activity levels and risk of coronary heart disease and death. The Multiple Risk Factor Intervention Trial. JAMA 1987;258:2388&#x2013;2395.</Citation><ArticleIdList><ArticleId IdType="pubmed">3669210</ArticleId></ArticleIdList></Reference><Reference><Citation>Paffenbarger RS Jr, Hyde RT, Hsieh CC, Wing AL.. Physical activity, other life-style patterns, cardiovascular disease and longevity. Acta Med Scand Suppl 1986;711:85&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">3535417</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaikh U, Lewis-Jones H.. VOMIT&#x2014;victim of medical investigative technology. BMJ 2008;336:8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2174745</ArticleId><ArticleId IdType="pubmed">18174573</ArticleId></ArticleIdList></Reference><Reference><Citation>Palange P, Ward SA, Carlsen K-H, Casaburi R, Gallagher CG, Gosselink R, O'Donnell DE, Puente-Maestu L, Schols AM, Singh S, Whipp BJ; ERS Task Force. Recommendations on the use of exercise testing in clinical practice. Eur Respir J 2007;29:185&#x2013;209.</Citation><ArticleIdList><ArticleId IdType="pubmed">17197484</ArticleId></ArticleIdList></Reference><Reference><Citation>Guazzi M, Adams V, Conraads V, Halle M, Mezzani A, Vanhees L, Arena R, Fletcher GF, Forman DE, Kitzman DW, Lavie CJ, Myers J; EACPR; AHA. EACPR/AHA Joint Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations. Eur Heart J 2012;33:2917&#x2013;2927.</Citation><ArticleIdList><ArticleId IdType="pubmed">22952138</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B&#xf6;hm M, Burri H, Butler J, &#x10c;elutkien&#x117; J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021;42:3599&#x2013;3726.</Citation><ArticleIdList><ArticleId IdType="pubmed">34447992</ArticleId></ArticleIdList></Reference><Reference><Citation>Brat K, Stastna N, Merta Z, Olson LJ, Johnson BD, Cundrle I.. Cardiopulmonary exercise testing for identification of patients with hyperventilation syndrome. PLoS One 2019;14:e0215997.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6478351</ArticleId><ArticleId IdType="pubmed">31013331</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels CJ, Rajpal S, Greenshields JT, Rosenthal GL, Chung EH, Terrin M, Jeudy J, Mattson SE, Law IH, Borchers J, Kovacs R, Kovan J, Rifat SF, Albrecht J, Bento AI, Albers L, Bernhardt D, Day C, Hecht S, Hipskind A, Mjaanes J, Olson D, Rooks YL, Somers EC, Tong MS, Wisinski J, Womack J, Esopenko C, Kratochvil CJ, Rink LD, Simonetti O, Zareba K, Bhatti S, Addison D, Obarski T, Daoud E, Granger M, Smart S, Mayercin-Johnson J, Subramanian P, Glitt J, Mitchell D, Chumita R, Mumford A, Garcia A, Garris L, Liu H, Hatfield B, Zhang Y, Boersma D, Schlader Z, Goodwin S, Port N, Zuidema T, Maldonado J, Eckhardt L, Reeder S, Baker M, Sebastianelli W, Wadlinger R, Millard R, Bosha P, Sunday H, Steele D, Chaudhry A, Smith S, Pfeiffer M, Kellerman J, Billy G, Krystofiak J, Eimer M; Big Ten COVID-19 Cardiac Registry Investigators. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection. Results from the Big Ten COVID-19 Cardiac Registry. JAMA Cardiol 2021;6:1078.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8160916</ArticleId><ArticleId IdType="pubmed">34042947</ArticleId></ArticleIdList></Reference><Reference><Citation>Udelson JE, Rowin EJ, Maron BJ.. Return to play for athletes after COVID-19 infection: the fog begins to clear. JAMA Cardiol 2021;6:997.</Citation><ArticleIdList><ArticleId IdType="pubmed">34042956</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>